Twist Bioscience Corp (TWST)

$44.87 2.14 (4.55%)

16:00 EDT TWST Stock Quote Delayed 30 Minutes

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life

By Ian Cooper, InvestorPlace Contributor May 10, 2024

Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.

TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024

3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition

7 Stocks Cathie Wood Is Still Loading Up On in Q1

More Articles

Volume:

Previous Close -

Market Cap 2.28B

PE Ratio -13.35

EPS -3.36

Volume (Avg. Vol.) 862,819

Day's Range $44.55 - $47.31

52-Week Range $13.11 - $50.50

Dividend & Yield N/A (N/A)

TWST Stock Predictions, Articles, and Twist Bioscience Corp News

From InvestorPlace
From the Web

7 Sexy Stocks That Will Continue to Outperform in 2024

By Matthew Farley, InvestorPlace Contributor Feb 11, 2024

These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the picks.

3 Genomics Stocks to Unlock the Future of Medicine

By Jeremy Flint, InvestorPlace Contributor Dec 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential

By John Blankenhorn, InvestorPlace Contributor Aug 11, 2023

DNA powers almost all biotechnology applications today. These leading DNA stocks are ready to reap the rewards of a growing industry.

3 DNA Stocks to Buy for the Synthetic Biology Revolution

By John Blankenhorn, InvestorPlace Contributor May 14, 2023

Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.

The 7 Best Biotech Stocks for Personalized Medicine Investors

By Alex Sirois, InvestorPlace Contributor Apr 25, 2023

Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics.

The Next Big Disruptors? 3 Biotech Stocks Making Headlines.

By John Blankenhorn, InvestorPlace Contributor Feb 17, 2023

Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023.

Why Is Twist Bioscience (TWST) Stock Down 18% Today?

By David Moadel, InvestorPlace Contributor Nov 15, 2022

TWST stock is cratering after a short seller issued a report with a startling target price and alarming accusations.

The 7 Best Biotech Stocks to Buy

By Dana Blankenhorn, InvestorPlace Contributor Sep 20, 2022

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

5 Top Stocks Cathie Wood Bought This Week

By Eddie Pan, InvestorPlace Financial News Writer Jul 21, 2022

Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks.

3 IPO Cathie Wood Stocks to Buy

By Chris Tyler, InvestorPlace Contributor Oct 7, 2021

It's time to follow the money in three Cathie Wood stocks, while sticking to the price charts in order to enjoy smarter money investments.

7 Long-Term Stocks to Buy With Your Tax Refund

By Faisal Humayun, InvestorPlace Contributor Apr 29, 2021

With your tax refund on its way, it's time to think about how to spend it. These stocks to buy are a mix of high-growth and dividend stocks.

A Golden Buying Opportunity Amid the Recent Tech Sector Meltdown

By Luke Lango, InvestorPlace Senior Investment Analyst Mar 12, 2021

Twist Biosciences (TWST) is a biology company developing a breakthrough synthetic DNA technology that has the potential to change the world.

4 IPOs to Watch This Week

By Tom Taulli, InvestorPlace Contributor Oct 29, 2018

There are four IPOs this week -- all small biotechs. But because of market turblence, it could be a tough environment for these offerings.

Twist Bioscience expands express genes service (NASDAQ:TWST)

From Seeking Alpha Jan 24, 2024

Twist Bioscience expands its gene synthesis service, Twist Express Genes, to include larger DNA preparations up to 1 milligram, with faster turnaround...

Goldman ups Twist Bioscience to buy, cites Express Genes service (NASDAQ:TWST)

From Seeking Alpha Jan 17, 2024

Goldman Sachs has upgraded Twist Bioscience (TWST) to buy, citing the potential of its new Express Genes gene synthesizing service to address gross margin issues. Read more here.

Twist Bioscience appoints Adam Laponis as CFO (NASDAQ:TWST)

From Seeking Alpha Jan 5, 2024

Twist Bioscience announces the appointment of Adam Laponis as CFO, who previously held positions at Eargo and Tesla.

Quants and short traders both love these stocks - who wins out?

From Seeking Alpha Dec 23, 2023

This article highlights stocks with high quant ratings and elevated short interest, indicating potential volatility.

Why Shares of Twist Bioscience Are Up Friday

From The Motley Fool Aug 4, 2023

The company reported improved financials in the third quarter.

2 Cathie Wood Growth Stocks That Could Make You Richer

From The Motley Fool Jul 18, 2023

These two biotechs could be winning plays for aggressive investors.

ADVERTISEMENT